Literature DB >> 21834612

The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs.

Kora DeBeck1, Thomas Kerr, Calvin Lai, Jane Buxton, Julio Montaner, Evan Wood.   

Abstract

BACKGROUND: Innovative health programs for injection drug users (IDUs), such as supervised injecting facilities (SIFs), are often preceded by evaluations of IDUs' willingness to use the service. The validity of these surveys has not been fully evaluated. We sought to determine whether measures of willingness collected prior to the opening of a Canadian SIF accurately predicted subsequent use of the program.
METHODS: Data were derived from a prospective cohort of IDUs. The sample size for this study was 640 IDUs. Using multivariate logistic regression, it was assessed if a history of reporting willingness to use the program, were it available, was associated with subsequent use. In sub-analysis restricted to individuals who had a history of reported willingness, we used multivariate longitudinal analysis to identify factors associated with not attending the SIF.
RESULTS: Among 442 IDUs, 72% of those who reported initial willingness to use a SIF later attended the program, and a prior willingness to use a SIF significantly predicted later attendance (adjusted odds ratio = 1.67). In sub-analyses restricted to those who had a history of reporting willingness to use the SIF, not using the program was predicted by not frequenting the neighborhood where the SIF was located.
CONCLUSION: Our findings indicate that reported willingness measures collected from IDUs regarding potential SIF program participation prior to its opening independently predicted later attendance even when variables that were likely determinants of willingness were adjusted for. These data suggest that willingness measures are reasonably valid tools for planning the delivery of health services among IDU populations.

Entities:  

Mesh:

Year:  2011        PMID: 21834612      PMCID: PMC3730831          DOI: 10.3109/00952990.2011.600389

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  36 in total

1.  Theories of reasoned action and planned behavior as models of condom use: a meta-analysis.

Authors:  D Albarracín; B T Johnson; M Fishbein; P A Muellerleile
Journal:  Psychol Bull       Date:  2001-01       Impact factor: 17.737

2.  Drug use and barriers to use of health care services.

Authors:  C B McCoy; L R Metsch; D D Chitwood; C Miles
Journal:  Subst Use Misuse       Date:  2001 May-Jun       Impact factor: 2.164

3.  Determinants of HAART discontinuation among injection drug users.

Authors:  T Kerr; A Marshall; J Walsh; A Palepu; M Tyndall; J Montaner; R Hogg; E Wood
Journal:  AIDS Care       Date:  2005-07

4.  Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Authors:  Steven Petrar; Thomas Kerr; Mark W Tyndall; Ruth Zhang; Julio S G Montaner; Evan Wood
Journal:  Addict Behav       Date:  2006-08-22       Impact factor: 3.913

5.  Using the Prototype/Willingness model to predict smoking behaviour among Norwegian adolescents.

Authors:  Silje Sommer Hukkelberg; Jennifer L Dykstra
Journal:  Addict Behav       Date:  2008-11-05       Impact factor: 3.913

6.  Do supervised injecting facilities attract higher-risk injection drug users?

Authors:  Evan Wood; Mark W Tyndall; Kathy Li; Elisa Lloyd-Smith; Will Small; Julio S G Montaner; Thomas Kerr
Journal:  Am J Prev Med       Date:  2005-08       Impact factor: 5.043

7.  Establishing safe injecting rooms in Australia: attitudes of injecting drug users.

Authors:  C Fry; S Fox; G Rumbold
Journal:  Aust N Z J Public Health       Date:  1999-10       Impact factor: 2.939

8.  Acceptability of a safer injection facility among injection drug users in San Francisco.

Authors:  Alex H Kral; Lynn Wenger; Lisa Carpenter; Evan Wood; Thomas Kerr; Philippe Bourgois
Journal:  Drug Alcohol Depend       Date:  2010-03-19       Impact factor: 4.492

9.  The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Authors:  Evan Wood; Thomas Kerr; Patricia M Spittal; Kathy Li; Will Small; Mark W Tyndall; Robert S Hogg; Michael V O'Shaughnessy; Martin T Schechter
Journal:  J Acquir Immune Defic Syndr       Date:  2003-01-01       Impact factor: 3.731

10.  Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia.

Authors:  Lucy Platt; Martin Wall; Tim Rhodes; Ali Judd; Matthew Hickman; Lisa G Johnston; Adrian Renton; Natalia Bobrova; Anya Sarang
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

View more
  12 in total

1.  Use of a medically supervised injection facility among street youth.

Authors:  Scott E Hadland; Kora DeBeck; Thomas Kerr; Paul Nguyen; Annick Simo; Julio S Montaner; Evan Wood
Journal:  J Adolesc Health       Date:  2014-06-09       Impact factor: 5.012

2.  Long-term benefits of providing transitional services to youth aging-out of the child welfare system: Evidence from a cohort of young people who use drugs in Vancouver, Canada.

Authors:  Brittany Barker; Jean Shoveller; Cameron Grant; Thomas Kerr; Kora DeBeck
Journal:  Int J Drug Policy       Date:  2020-09-01

3.  Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.

Authors:  Sasha Uhlmann; Michael John Milloy; Keith Ahamad; Paul Nguyen; Thomas Kerr; Evan Wood; Lindsey Richardson
Journal:  Am J Addict       Date:  2015-03-24

4.  Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.

Authors:  Sanjana Mitra; Beth Rachlis; Ayden Scheim; Geoff Bardwell; Sean B Rourke; Thomas Kerr
Journal:  Harm Reduct J       Date:  2017-07-14

5.  High willingness to use rapid fentanyl test strips among young adults who use drugs.

Authors:  Maxwell S Krieger; Jesse L Yedinak; Jane A Buxton; Mark Lysyshyn; Edward Bernstein; Josiah D Rich; Traci C Green; Scott E Hadland; Brandon D L Marshall
Journal:  Harm Reduct J       Date:  2018-02-08

6.  Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.

Authors:  Benjamin A Bouvier; Beth Elston; Scott E Hadland; Traci C Green; Brandon D L Marshall
Journal:  Harm Reduct J       Date:  2017-02-20

7.  Potential use of supervised injection services among people who inject drugs in a remote and mid-size Canadian setting.

Authors:  Sanjana Mitra; Beth Rachlis; Bonnie Krysowaty; Zack Marshall; Cynthia Olsen; Sean Rourke; Thomas Kerr
Journal:  BMC Public Health       Date:  2019-03-08       Impact factor: 3.295

8.  Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.

Authors:  Allison O'Rourke; Rebecca Hamilton White; Ju Nyeong Park; Kayla Rodriguez; Michael E Kilkenny; Susan G Sherman; Sean T Allen
Journal:  Harm Reduct J       Date:  2019-08-31

9.  Factors associated with willingness to wear an electronic overdose detection device.

Authors:  Keith Ahamad; Huiru Dong; Cheyenne Johnson; Kanna Hyashi; Kora DeBeck; M J Milloy; Evan Wood
Journal:  Addict Sci Clin Pract       Date:  2019-07-03

10.  Risk environments facing potential users of a supervised injection site in Ottawa, Canada.

Authors:  Ashley Shaw; Lisa Lazarus; Tyler Pantalone; Sean LeBlanc; Dolly Lin; Daina Stanley; Caleb Chepesiuk; Sheetal Patel; Mark Tyndall
Journal:  Harm Reduct J       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.